Essential Hypertension
Conditions
Interventions
None listed
Sponsors
Ajinomoto Pharmaceuticals Co., LTD.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Atelec-naive patients with essential hypertension
Exclusion criteria
Exclusion criteria: Pregnant or possibly pregnant patients
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in blood pressure levels at home (early morning and before bedtime) or in physician's office | — |
Secondary
| Measure | Time frame |
|---|---|
| Adverse events | — |
Countries
Japan
Contacts
Public ContactEiichi Ohara
Mochida Pharmaceutical Co.,Ltd. Post-Marketing Surveillance
Outcome results
None listed